Wikisage, the free encyclopedia of the second generation, is digital heritage
Stiripentol: Difference between revisions
Jump to navigation
Jump to search
(]]) |
(link fix) |
||
| Line 3: | Line 3: | ||
==Use== | ==Use== | ||
<ref>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652007/pdf/nihms266887.pdf</ref> | <ref>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652007/pdf/nihms266887.pdf</ref> | ||
==Dravet | ==[[Dravet's Syndrome]]== | ||
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913306/pdf/i1535-7511-14-1-22.pdf Stiripentol for Dravet Syndrome: Is It Worth It?]<ref>https://static-content.springer.com/lookinside/art%3A10.1007%2Fs40263-012-0004-3/000.png</ref> | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913306/pdf/i1535-7511-14-1-22.pdf Stiripentol for Dravet Syndrome: Is It Worth It?]<ref>https://static-content.springer.com/lookinside/art%3A10.1007%2Fs40263-012-0004-3/000.png</ref> | ||
<ref>[http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/epdf Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders]</ref><ref>[http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2006.00497.x/pdf Stiripentol, a Putative Antiepileptic Drug, Enhances the Duration of Opening of GABAA-Receptor Channels]</ref><ref>http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/000664/WC500036518.pdf</ref><ref>http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2011.03008.x/epdf</ref> | <ref>[http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/epdf Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders]</ref><ref>[http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2006.00497.x/pdf Stiripentol, a Putative Antiepileptic Drug, Enhances the Duration of Opening of GABAA-Receptor Channels]</ref><ref>http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/000664/WC500036518.pdf</ref><ref>http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2011.03008.x/epdf</ref> | ||
Revision as of 03:37, 13 December 2016
Stipiripentol is adjuvant of clobazam and valproic acid[1][2] [3]
Use
Dravet's Syndrome
Stiripentol for Dravet Syndrome: Is It Worth It?[5] [6][7][8][9]
-Stiripentol_Structural_Formulae_V.1.svg.png)
Links
FLexikon:Stiripentol
Interwiki via Wikidata
Notes
- ↑ Chiron Catherine 2007 Neurotherapeutics 123-125
- ↑ Pharmacological Reports
- ↑ Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
- ↑ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652007/pdf/nihms266887.pdf
- ↑ https://static-content.springer.com/lookinside/art%3A10.1007%2Fs40263-012-0004-3/000.png
- ↑ Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- ↑ Stiripentol, a Putative Antiepileptic Drug, Enhances the Duration of Opening of GABAA-Receptor Channels
- ↑ http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/000664/WC500036518.pdf
- ↑ http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2011.03008.x/epdf
- ↑ The European patient with Dravet syndrome: Results from abparent-reported survey on antiepileptic drug use in the European population with Dravet syndrome
